Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : opens drive-through COVID-19 testing sites in Atlanta, R.I.

share with twitter share with LinkedIn share with facebook
share via e-mail
04/06/2020 | 10:01am EDT

Pharmacy chain CVS Health has opened drive-through coronavirus testing sites in Georgia and Rhode Island, the company announced Monday.

The sites -- one at the Georgia Institute of Technology in Atlanta and another at Twin River Casino near Providence, R.I. -- will be staffed by licensed health care providers from CVS' MinuteClinic subsidiary, the company said.

The sites will perform the Abbott ID NOW COVID-19 test, which last month received emergency use authorization from the Food and Drug Administration. The test can achieve positive results as quickly as 5 minutes and negative results in as few as 13 minutes.

CVS said the tests are free and available to those who meet criteria established by the Centers for Disease Control and Prevention. People must make a reservation for the drive-through test through the CVS website.

Georgia Gov. Brian Kemp called the Atlanta testing site "a unique, public-private partnership" that would "strengthen our testing capability," while Rhode Island Gov. Gina Raimondo called the Providence location "a giant leap forward in our efforts to combat this virus."

CVS said both sites will utilize safety and efficiency lessons learned from the chain's first drive-through testing location, which opened March 19 in Shrewsbury, Mass.

Copyright 2020 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent., source US Top News

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CVS HEALTH CORPORATION
05/26Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmake..
RE
05/26Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmake..
RE
05/22The Job Market's Long Road Back
DJ
05/21CVS HEALTH : Expands Statewide COVID-19 Response By Opening 16 Additional New Dr..
PR
05/21CVS HEALTH : Opens 8 New Drive-Thru Test Sites in Louisiana as Part of Nationwid..
PR
05/21CVS HEALTH : Opens 21 New Drive-Thru Test Sites in Indiana as Part of Nationwide..
PR
05/21CVS HEALTH : Expands Statewide COVID-19 Response By Opening 27 Additional New Dr..
PR
05/21CVS HEALTH : Opens 36 New Drive-Thru Test Sites in New York as Part of Nationwid..
PR
05/21CVS HEALTH : Opens 11 New Drive-Thru Test Sites in New Jersey as Part of Nationw..
PR
05/21CVS HEALTH : Opens 44 New Drive-Thru Test Sites in Texas as Part of Nationwide C..
PR
More news
Financials (USD)
Sales 2020 266 B
EBIT 2020 15 516 M
Net income 2020 7 344 M
Debt 2020 55 997 M
Yield 2020 3,09%
P/E ratio 2020 11,7x
P/E ratio 2021 10,6x
EV / Sales2020 0,53x
EV / Sales2021 0,49x
Capitalization 84 490 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 79,80 $
Last Close Price 64,64 $
Spread / Highest target 68,6%
Spread / Average Target 23,5%
Spread / Lowest Target 2,10%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors